Gene · 3848
Papers2,853
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,853
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinicopathological characteristics and genetic alterations in clear cell carcinoma cells derived from Mullerian duct epithelium of the prostate. | Chin Med J (Engl) | 2022 | 36583865 | PubTator, text mining | PubMed |
| Characteristic analysis of skin keratinocytes in patients with type 2 diabetes based on the single-cell levels. | Chin Med J (Engl) | 2022 | 36583863 | PubTator, text mining | PubMed |
| Ipsilateral Verrucous Epidermal Nevus with Woolly Hair Nevus: A Unique Association. | Indian J Dermatol | 2022 | 36578735 | PubTator, text mining | PubMed |
| Integrated single-cell transcriptome analysis of the tumor ecosystems underlying cervical cancer metastasis. | Front Immunol | 2022 | 36569924 | PubTator, text mining | PubMed |
| Tear-derived exosomal biomarkers of Graves' ophthalmopathy. | Front Immunol | 2022 | 36561758 | PubTator, text mining | PubMed |
| Identifying hub genes, key pathways and key immune-related genes in Peyronie's disease by integrated bioinformatic analysis. | Front Pharmacol | 2022 | 36561343 | PubTator, text mining | PubMed |
| Corroboration of cross-reactivity between Mycobacterium leprae and hosts' salivary and cutaneous proteins: A hope for prognostic biomarkers for the pathogenesis of reactions in leprosy. | Front Microbiol | 2022 | 36560940 | PubTator, text mining | PubMed |
| Interaction of Colloidal Gold Nanoparticles with Urine and Saliva Biofluids: An Exploratory Study. | Nanomaterials (Basel) | 2022 | 36558287 | PubTator, text mining | PubMed |
| The Role of Sphingolipids in the Pathogenesis of Psoriasis. | Metabolites | 2022 | 36557209 | PubTator, text mining | PubMed |
| The J Domain of Sacsin Disrupts Intermediate Filament Assembly. | Int J Mol Sci | 2022 | 36555380 | PubTator, text mining | PubMed |
| Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases. | Cells | 2022 | 36552866 | PubTator, text mining | PubMed |
| SETD7 Expression Is Associated with Breast Cancer Survival Outcomes for Specific Molecular Subtypes: A Systematic Analysis of Publicly Available Datasets. | Cancers (Basel) | 2022 | 36551516 | PubTator, text mining | PubMed |
| Surface protein profiling of prostate-derived extracellular vesicles by mass spectrometry and proximity assays. | Commun Biol | 2022 | 36550367 | PubTator, text mining | PubMed |
| Proteomics Evaluation of Semen of Clinically Healthy Beagle-Breed Dogs. | Vet Sci | 2022 | 36548858 | PubTator, text mining | PubMed |
| Targeting the transcription factor HES1 by L-menthol restores protein phosphatase 6 in keratinocytes in models of psoriasis. | Nat Commun | 2022 | 36535970 | PubTator, text mining | PubMed |
| Compact automated culture machine for human induced pluripotent stem cell maintenance and differentiation. | Front Bioeng Biotechnol | 2022 | 36524054 | PubTator, text mining | PubMed |
| Effect of M6A regulators on diagnosis, subtype classification, prognosis and novel therapeutic target development of idiopathic pulmonary fibrosis. | Front Pharmacol | 2022 | 36518679 | PubTator, text mining | PubMed |
| Differentiation of pluripotent stem cells for modeling human skin development and potential applications. | Front Cell Dev Biol | 2022 | 36506084 | PubTator, text mining | PubMed |
| OMICS Approaches Evaluating Keloid and Hypertrophic Scars. | Int J Inflam | 2022 | 36483731 | PubTator, text mining | PubMed |
| LY6D marks pre-existing resistant basosquamous tumor subpopulations. | Nat Commun | 2022 | 36473848 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3848/papers?page=19